Officer reports multiple common stock sales

Rhea-AI Filing Summary

TWST-related filing: A Form 144 notice reports insider sales of Common stock by Adam Laponis. The filing lists multiple dispositions during April–May 2026 with per-trade share counts and proceeds recorded. It also shows a planned/security line item for Common with a 07/08/2025 vesting reference.

Insights

Corporate Governance Analyst

TL;DR: Multiple reported dispositions by an individual insider across April–May 2026.

The filing records several sales by Adam Laponis, including transactions on 04/09/2026, 04/14/2026, 04/17/2026, 05/21/2026, and 05/29/2026, with each trade showing shares and proceeds.

These are disclosure transactions under securities resale rules; cashflow treatment and whether trades were pre-arranged are not stated in the excerpt. Subsequent filings or trade confirmations would provide additional context.

Key Figures

Sale on 04/09/2026: 2,597 shares Sale on 04/14/2026: 3,000 shares Sale on 04/17/2026: 4,000 shares +4 more

7 metrics

Sale on 04/09/2026 2,597 shares Proceeds <money>$129,561.48</money>

Sale on 04/14/2026 3,000 shares Proceeds <money>$165,000.00</money>

Sale on 04/17/2026 4,000 shares Proceeds <money>$240,000.00</money>

Sale on 05/21/2026 2,019 shares Proceeds <money>$107,525.08</money>

Sale on 05/29/2026 4,000 shares Proceeds <money>$280,000.00</money>

Securities listed to be sold 2,399 shares Line item in "Securities To Be Sold" section

Restricted stock vesting date 07/08/2025 Labeled "Restricted Stock Vesting" in filing

Key Terms

Form 144, Restricted Stock Vesting, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 07/08/2025 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

What does the TWST Form 144 filed here show?

The Form 144 reports multiple insider sales by Adam Laponis. It lists individual trades with share counts and proceeds recorded on specific dates in April and May 2026, and a separate line referencing restricted stock vesting on 07/08/2025.

How many shares did Adam Laponis sell on April 17, 2026 (TWST)?

On 04/17/2026, the filing lists a sale of 4,000 shares of Common stock with proceeds of $240,000.00. The entry appears in the filing's "Securities Sold During The Past 3 Months" section.

Are the proceeds from the listed sales shown in the filing?

Yes. Each reported transaction in the excerpt pairs a share count with a proceeds amount, for example $129,561.48 for 2,597 shares on 04/09/2026. The filing shows proceeds per trade rather than aggregate proceeds.

Does this Form 144 show when restricted shares vested for TWST?

The excerpt includes a line labeled "Restricted Stock Vesting" with a date of 07/08/2025. That line appears in the "Securities To Be Sold" area, indicating a vesting-related item in the filing's schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/09/2026 - 03:15 PM Accepted by SEC EDGAR 07/09/2026 - 03:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001827198
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	Laponis Adam
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2399	226306.06	62271314	07/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/08/2025	Restricted Stock Vesting	Issuer			2399	07/08/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Laponis 681 Gateway Blvd South San Francisco CA 94080	Common	04/09/2026	2597	129561.48
Adam Laponis 681 Gateway Blvd South San Francisco CA 94080	Common	04/14/2026	3000	165000.00
Adam Laponis 681 Gateway Blvd South San Francisco CA 94080	Common	04/17/2026	4000	240000.00
Adam Laponis 681 Gateway Blvd South San Francisco CA 94080	Common	05/21/2026	2019	107525.08
Adam Laponis 681 Gateway Blvd South San Francisco CA 94080	Common	05/29/2026	4000	280000.00

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	07/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adam Laponis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)